Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept vs Cyclophosphamide/Azathioprine in Lupus Nephritis
NCT00425438Phase 3Terminated
- Sponsor
- Roche
- Start
- Mar 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mycophenolate mofetil in lupus nephritis (LN) (2 arms), sponsored by Roche. Primary endpoint: Complete Response at 48 weeks. Started Mar 2007; status: terminated.
02
Drugs
mycophenolate mofetil
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00425438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425438.